Parkinson Disease
7 competing products in clinical development for Parkinson Disease.
Pipeline by Phase
Pre-clinical2
Phase 11
Phase 22
Approved2
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Safinamide Mesilate | Eisai | Approved | Completed | 43 |
| Istradefylline Pill | Kyowa Kirin | Approved | Completed | 43 |
| exidavnemab + Placebo Comparator | BioArctic AB | Phase 2 | Active | 36 |
| LY4006896 + Placebo | Eli Lilly | Phase 1 | Recruiting | 36 |
| Istradefylline medication | Kyowa Kirin | Phase 2 | Completed | 35 |
| Equfina 50 mg | Eisai | Pre-clinical | Completed | 26 |
| Equfina | Eisai | Pre-clinical | Completed | 26 |